{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:13:54Z","timestamp":1789992834527,"version":"4.0.1"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CCDT"],"published-print":{"date-parts":[[2011,3,1]]},"DOI":"10.2174\/156800911794519734","type":"journal-article","created":{"date-parts":[[2011,2,7]],"date-time":"2011-02-07T09:18:51Z","timestamp":1297070331000},"page":"347-356","source":"Crossref","is-referenced-by-count":130,"title":["SCF E3 Ubiquitin Ligases as Anticancer Targets"],"prefix":"10.2174","volume":"11","author":[{"given":"L.","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Cancer Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/73312","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T08:37:25Z","timestamp":1448267845000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1568-0096&volume=11&issue=3&spage=347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,1]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/156800911794519734","relation":{},"ISSN":["1568-0096"],"issn-type":[{"value":"1568-0096","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3,1]]}}}